Concepedia

Woods Wannamaker

WW

1

Publications

309

Citations

1

H-Index

2007

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Woods Wannamaker is an author at Vertex Pharmaceuticals (United States).

Publications per year

2007–2007

1

Publications

1

(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1β and IL-18

Woods Wannamaker, Robert M. D. Davies, Mark Namchuk et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 309 citations

Rows per page

1–1 of 1